BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Vote In favor of Your Favored Sort Of Dress - 2Abbott issues US device correction for some glucose monitors over faulty readings risk
- 3Gaza amputees struggle to rebuild lives as the enclave faces shortages of prosthetic limbs
- 4IDF kills senior PIJ Gaza City Brigade cmdr. who infiltrated Kibbutz Nahal Oz on Oct. 7
- 56 Trail blazing Bicycles for Rough terrain Undertakings
- Cognizant Couture d: A Survey of \Moral Decisions and Sharp Looks\ Maintainable Style
- Closets for Your Room: Plan and Utility Features
- Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- Seven deaths possibly linked to malfunctioning glucose monitors
- Criminal Guard Lawyer Expenses: What Would it be advisable for you to Hope to Pay?
- Europe picks companies to help build Argonaut moon lander
- Fiber is something most people could use more of. But experts advise caution with 'fibermaxxing'
- The Minimized Passage Horse: Reconsidering a Symbol for the Cutting edge Period
- Astronomers discover never-before-seen celestial object: "Cloud 9"
